rs147706488
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004565.3(PEX14):āc.575C>Gā(p.Ala192Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00106 in 1,608,406 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A192T) has been classified as Uncertain significance.
Frequency
Consequence
NM_004565.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX14 | NM_004565.3 | c.575C>G | p.Ala192Gly | missense_variant | 7/9 | ENST00000356607.9 | NP_004556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX14 | ENST00000356607.9 | c.575C>G | p.Ala192Gly | missense_variant | 7/9 | 1 | NM_004565.3 | ENSP00000349016.4 |
Frequencies
GnomAD3 genomes AF: 0.000709 AC: 108AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000678 AC: 170AN: 250810Hom.: 1 AF XY: 0.000758 AC XY: 103AN XY: 135798
GnomAD4 exome AF: 0.00110 AC: 1598AN: 1456068Hom.: 4 Cov.: 30 AF XY: 0.00112 AC XY: 814AN XY: 724698
GnomAD4 genome AF: 0.000709 AC: 108AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000671 AC XY: 50AN XY: 74488
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.575C>G (p.A192G) alteration is located in exon 7 (coding exon 7) of the PEX14 gene. This alteration results from a C to G substitution at nucleotide position 575, causing the alanine (A) at amino acid position 192 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 06, 2018 | - - |
Peroxisome biogenesis disorder 13A (Zellweger) Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
PEX14-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 08, 2023 | The PEX14 c.575C>G variant is predicted to result in the amino acid substitution p.Ala192Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.11% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Peroxisome biogenesis disorder, complementation group K Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at